Senti Biosciences(@SentiBio ):Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025 https://t.co/1p4qnMjopA @AACR

Senti Biosciences

@SentiBio

Outsmarting complex diseases with more intelligent medicines

Joined June 2016

92 Following 1.8K Followers

Senti Biosciences@SentiBio

2025.04.03 14:56

Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025 https://t.co/1p4qnMjopA @AACR https://t.co/XIfEPdmLbZ